rs199473348
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000219.6(KCNE1):c.23C>T(p.Ala8Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000097 ( 0 hom., cov: 13)
Exomes 𝑓: 0.00010 ( 7 hom. )
Consequence
KCNE1
NM_000219.6 missense
NM_000219.6 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 1.19
Genes affected
KCNE1 (HGNC:6240): (potassium voltage-gated channel subfamily E regulatory subunit 1) The product of this gene belongs to the potassium channel KCNE family. Potassium ion channels are essential to many cellular functions and show a high degree of diversity, varying in their electrophysiologic and pharmacologic properties. This gene encodes a transmembrane protein known to associate with the product of the KVLQT1 gene to form the delayed rectifier potassium channel. Mutation in this gene are associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.08138129).
BS2
High Homozygotes in GnomAdExome4 at 7 AD,AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNE1 | NM_000219.6 | c.23C>T | p.Ala8Val | missense_variant | 4/4 | ENST00000399286.3 | NP_000210.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNE1 | ENST00000399286.3 | c.23C>T | p.Ala8Val | missense_variant | 4/4 | 1 | NM_000219.6 | ENSP00000382226.2 |
Frequencies
GnomAD3 genomes AF: 0.0000969 AC: 9AN: 92872Hom.: 0 Cov.: 13
GnomAD3 genomes
AF:
AC:
9
AN:
92872
Hom.:
Cov.:
13
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251178Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135844
GnomAD3 exomes
AF:
AC:
26
AN:
251178
Hom.:
AF XY:
AC XY:
19
AN XY:
135844
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000102 AC: 81AN: 795706Hom.: 7 Cov.: 11 AF XY: 0.000103 AC XY: 42AN XY: 409650
GnomAD4 exome
AF:
AC:
81
AN:
795706
Hom.:
Cov.:
11
AF XY:
AC XY:
42
AN XY:
409650
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000968 AC: 9AN: 92948Hom.: 0 Cov.: 13 AF XY: 0.000134 AC XY: 6AN XY: 44890
GnomAD4 genome
AF:
AC:
9
AN:
92948
Hom.:
Cov.:
13
AF XY:
AC XY:
6
AN XY:
44890
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
15
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:7Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jan 13, 2020 | Variant summary: KCNE1 c.23C>T (p.Ala8Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00011 in 251512 control chromosomes. The observed variant frequency is approximately 10.7- fold the estimated maximal expected allele frequency for a pathogenic variant in KCNE1 causing Arrhythmia phenotype (1e-05), suggesting that the variant is benign. However, c.23C>T has been reported in the literature in multiple individuals affected with arrhythmia (e.g. Ohno_2007, Sale_2008, Kapplinger_2009, Fedida_2017, Bennett_2019, Li_2019), including three individuals from one family in which the variant segregated with a Long QT Syndrome (LQTS) phenotype (Li_2019). These data indicate that the variant may be associated with disease. At least three publications report experimental evidence evaluating the electrophysiological effects of the variant on potassium channels and suggest that the variant may alter channel kinetics, however the biological consequences fo these findings are not clear (e.g. Ohno_2007, Sale, 2008, Du_2013). Four other ClinVar submitters (evaluation after 2014) have cited the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 09, 2018 | The p.Ala8Val variant in KCNE1 has been reported in the heterozygous state in on e individual with paroxysmal atrial fibrillation and sick sinus syndrome and one individual with Long QT syndrome (Ohno 2007, Sale 2008, Kapplinger 2009). This variant has been identified in 11/18860 East Asian chromosomes by the Genome Agg regation Database (gnomAD, http://gnomad.broadinstitute.org/) and is reported in ClinVar (Variation ID: 132670). In vitro functional studies provide some eviden ce that the p.Ala8Val variant may impact protein function (Ohno 2007, Sale 2008, Du 2013). However, these types of assays may not accurately represent biologica l function. Alanine (Ala) at position 8 is not conserved in mammals or evolution arily distant species and 4 mammals carry a Valine (Val) at this position, raisi ng the possibility that this change may be tolerated. Additional computational p rediction tools suggest that the p.Ala8Val variant may not impact the protein, t hough this information is not predictive enough to rule out pathogenicity. In su mmary, the clinical significance of the p.Ala8Val variant is uncertain. ACMG/AMP Criteria applied: PS3_Supporting, PS4_Supporting, BP4_Strong. - |
Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 8 of the KCNE1 protein (p.Ala8Val). This variant is present in population databases (rs199473348, gnomAD 0.06%). This missense change has been observed in individual(s) with long QT syndrome or clinical suspicion of long QT syndrome (PMID: 17341399, 19716085, 31521807, 31535183, 34403091). ClinVar contains an entry for this variant (Variation ID: 132670). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KCNE1 protein function with a negative predictive value of 95%. Experimental studies have shown that this missense change affects KCNE1 function (PMID: 17341399, 18776039, 24400172). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | Low GERP score may suggest that this variant may belong in a lower pathogenicity class - |
Long QT syndrome 5 Uncertain:1Other:1
not provided, no classification provided | in vitro | Roden Lab, Vanderbilt University Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | curation | SIB Swiss Institute of Bioinformatics | May 31, 2018 | This variant is interpreted as a Uncertain Significance - Conflicting Evidence, for Long QT syndrome 5, in Autosomal Dominant manner. The following ACMG Tag(s) were applied: BS1 => Allele frequency is greater than expected for disorder. PS3-Moderate => PS3 downgraded in strength to Moderate (PMID:18776039). - |
Long QT syndrome 5;C2676723:Jervell and Lange-Nielsen syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 15, 2021 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2021 | The c.23C>T (p.A8V) alteration is located in exon 3 (coding exon 1) of the KCNE1 gene. This alteration results from a C to T substitution at nucleotide position 23, causing the alanine (A) at amino acid position 8 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:17341399;PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Uncertain
D;D;D;D;D;D;D;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;.;T;.;.;.;.;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
M;M;M;M;M;M;M;M
PrimateAI
Benign
T
PROVEAN
Benign
N;.;.;N;N;N;N;N
REVEL
Uncertain
Sift
Benign
D;.;.;D;D;D;D;D
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
B;B;B;B;B;B;B;B
Vest4
MVP
MPC
0.079
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at